Treating non-Hodgkin's lymphoma (NHL) patients with radiation therapy as an additional treatment while they wait for their CAR T cells to be manufactured may reduce the risk of CAR T therapy side effects once it is administered.
from Latest Science News -- ScienceDaily https://ift.tt/3084FqH
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment